2024-12-28 04:51:01
Akeso Inc. Announces Collaboration and License Agreement for Up to US$5 Billion with Summit Therapeutics to Accelerate Global Development and Commercialization of its Breakthrough Bispecific Antibody, Ivonescimab (PD-1/VEGF)
Corporate/ 2023-07-24
Akeso Inc. Announces Collaboration and L...

Akeso Inc. to out-license to Summit Therapeutics exclusive rights to ivonescimab (PD-1/VEGF) for the development and commercialization in th...

Newtown's Apple to Highly Saturated Global Molecular Market, TIANGEN TGuide S16 Automated Nucleic Acid Extractor Showcased at Cell Bio 2022
Health/ 2023-07-22
Newtown's Apple to Highly Saturated...

WASHINGTON,Dec. 6,2022-- TIANGEN,a high-tech biological enterprise,demonstrated its revolutionary nucleic acid extraction solution at Cell B...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release